A detailed history of Capstone Investment Advisors, LLC transactions in Accelerate Diagnostics, Inc stock. As of the latest transaction made, Capstone Investment Advisors, LLC holds 25,000 shares of AXDX stock, worth $48,250. This represents 0.0% of its overall portfolio holdings.

Number of Shares
25,000
Holding current value
$48,250
% of portfolio
0.0%

Shares

0 transactions
Quarter Operation Price Per share shares change shares Held SEC Form

Others Institutions Holding AXDX

About Accelerate Diagnostics, Inc


  • Ticker AXDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 99,059,904
  • Market Cap $191M
  • Description
  • Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious ...
More about AXDX
Track This Portfolio

Track Capstone Investment Advisors, LLC Portfolio

Follow Capstone Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capstone Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capstone Investment Advisors, LLC with notifications on news.